Serelaxin

N/A

Report date: 2022/01/14 13:23:58
First In Class

Base Information

Drug NameSerelaxin
Drug Alias NameRLX-030SUN-Y8002RLX-030A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionRelaxin receptor 1 agonists
TargetsRelaxin receptor 1
Therapy Area/IndicationsLabor, InducedFibrosisCoronary Artery Disease +[10
Global Approved IndicationsFibrosisCoronary DiseaseHeart Failure +[4
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2015/01/01
Country/TerritoryCzechiaBelgiumBulgaria +[55
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsFibrosisCoronary DiseaseHeart Failure +[4
Inactive IndicationsLabor, InducedCoronary Artery DiseasePre-Eclampsia +[6

Other Information

ATC CodeC01DX21
Related LinksWikipediaKEGG